ArticleBriefings in bioinformatics2025
Predicting disease associations based on the higher order structure of ceRNA networks.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- MCOAN: multimodal contrastive representation learning for cross-omics adaptive disease regulatory network prediction.Bioinformatics (Oxford, England) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Competitive endogenous RNA (ceRNA) network regulation is an important posttranscriptional regulatory mechanism that plays an important role in physiological and pathological processes, and has been widely used in biomarker screening and regulatory factor studies of disease-related genes. However, existing studies have mainly focused on the association of a single type of RNA with disease, while studies targeting the application of ceRNA networks in disease prediction are still limited, so it is crucial to explore the potential of ceRNA networks in disease prediction. In this study, we propose CERDA-HOSR, a computational method for mining ceRNA network-disease associations based on higher order graph attention networks. The method uses higher order graph convolutional networks to aggregate neighborhood information to generate representations of different RNAs and diseases. Given the higher order complexity of biological networks and sample imbalance problem, traditional random negative sampling is difficult to effectively capture global information; for this reason, a higher order negative sampling strategy is designed to optimize the quality of negative samples by combining the network structure and higher order neighborhood relations to improve the generalization ability and prediction accuracy of the model. Finally, LightGBM calculates the ceRNA network-disease association probability based on the learned embedding. A large number of simulation experiments validate the superiority of CERDA-HOSR, and its practical application is further demonstrated by case studies of cardiovascular disease, acute myeloid leukemia, and papillary thyroid cancer. In addition, ablation experiments and exploratory analyses further enhance its robustness and provide an effective tool for disease prediction and biomarker screening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.